These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21093860)

  • 21. Drug repurposing by in silico prediction of cyclizine derivatives as antihyperlipemic agents.
    Afanamol MS; Dinesh AD; Ali KS; Vengamthodi A; Rasheed A
    In Silico Pharmacol; 2023; 11(1):27. PubMed ID: 37899967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unwrapped and uNCORked: PPAR-γ repression in atherosclerosis.
    Van der Vorst EPC; Biessen EAL
    Eur Heart J; 2022 Feb; 43(7):e32-e34. PubMed ID: 31754688
    [No Abstract]   [Full Text] [Related]  

  • 23. A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD.
    Srivastava RAK
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological Profile, Bioactivities, and Safety of Turmeric Oil.
    Orellana-Paucar AM; Machado-Orellana MG
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Peroxisome Proliferator-Activated Receptor Gamma and Atherosclerosis: Post-translational Modification and Selective Modulators.
    Yin L; Wang L; Shi Z; Ji X; Liu L
    Front Physiol; 2022; 13():826811. PubMed ID: 35309069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis.
    Srivastava N; Cefalu AB; Averna M; Srivastava RAK
    Front Physiol; 2018; 9():1222. PubMed ID: 30271349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of lipid metabolism by obeticholic acid in hyperlipidemic hamsters.
    Dong B; Young M; Liu X; Singh AB; Liu J
    J Lipid Res; 2017 Feb; 58(2):350-363. PubMed ID: 27940481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212-2 on Atherosclerosis in Ldlr-null Mice.
    Netherland-Van Dyke C; Rodgers W; Fulmer M; Lahr Z; Thewke D
    J Cardiol Ther; 2015 Jul; 3(2):53-63. PubMed ID: 26413498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apple Polyphenols Decrease Atherosclerosis and Hepatic Steatosis in ApoE-/- Mice through the ROS/MAPK/NF-κB Pathway.
    Xu ZR; Li JY; Dong XW; Tan ZJ; Wu WZ; Xie QM; Yang YM
    Nutrients; 2015 Aug; 7(8):7085-105. PubMed ID: 26305254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome Proliferator-Activated Receptor Gamma Promotes Mesenchymal Stem Cells to Express Connexin43 via the Inhibition of TGF-β1/Smads Signaling in a Rat Model of Myocardial Infarction.
    Hou J; Wang L; Hou J; Guo T; Xing Y; Zheng S; Zhou C; Huang H; Long H; Zhong T; Wu Q; Wang J; Wang T
    Stem Cell Rev Rep; 2015 Dec; 11(6):885-99. PubMed ID: 26275398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood Lipid Distribution, Aortic Cholesterol Concentrations, and Selected Inflammatory and Bile Metabolism Markers in Syrian Hamsters Fed a Standard Breeding Diet.
    Stephens AM; Sanders TH
    J Am Assoc Lab Anim Sci; 2015 Jul; 54(4):353-8. PubMed ID: 26224433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes.
    Srivastava RA; Mistry S; Sharma S
    Nutr Metab (Lond); 2015; 12():20. PubMed ID: 26064179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.
    Kan CF; Singh AB; Dong B; Shende VR; Liu J
    Biochim Biophys Acta; 2015 May; 1851(5):577-87. PubMed ID: 25645621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of full-length cholesteryl ester transfer protein in SW872 cells reduces lipid accumulation.
    Izem L; Greene DJ; Bialkowska K; Morton RE
    J Lipid Res; 2015 Mar; 56(3):515-525. PubMed ID: 25593327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current guidelines for high-density lipoprotein cholesterol in therapy and future directions.
    Subedi BH; Joshi PH; Jones SR; Martin SS; Blaha MJ; Michos ED
    Vasc Health Risk Manag; 2014; 10():205-16. PubMed ID: 24748800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression.
    Hulsmans M; Geeraert B; Arnould T; Tsatsanis C; Holvoet P
    PLoS One; 2013; 8(4):e62253. PubMed ID: 23620818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-fructose diet downregulates long-chain acyl-CoA synthetase 3 expression in liver of hamsters via impairing LXR/RXR signaling pathway.
    Dong B; Kan CF; Singh AB; Liu J
    J Lipid Res; 2013 May; 54(5):1241-54. PubMed ID: 23427282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism.
    Pinkosky SL; Filippov S; Srivastava RA; Hanselman JC; Bradshaw CD; Hurley TR; Cramer CT; Spahr MA; Brant AF; Houghton JL; Baker C; Naples M; Adeli K; Newton RS
    J Lipid Res; 2013 Jan; 54(1):134-51. PubMed ID: 23118444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases.
    Srivastava RA; Pinkosky SL; Filippov S; Hanselman JC; Cramer CT; Newton RS
    J Lipid Res; 2012 Dec; 53(12):2490-514. PubMed ID: 22798688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.
    Mahdy Ali K; Wonnerth A; Huber K; Wojta J
    Br J Pharmacol; 2012 Nov; 167(6):1177-94. PubMed ID: 22725625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.